Published in Am J Physiol on June 01, 1999
Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev (2007) 4.91
Glucolipotoxicity of the pancreatic beta cell. Biochim Biophys Acta (2009) 1.69
Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. J Clin Invest (2000) 1.58
Sodium phenylbutyrate, a drug with known capacity to reduce endoplasmic reticulum stress, partially alleviates lipid-induced insulin resistance and beta-cell dysfunction in humans. Diabetes (2011) 1.29
Insulin enhances glucose-stimulated insulin secretion in healthy humans. Proc Natl Acad Sci U S A (2010) 1.25
Peroxisome-generated hydrogen peroxide as important mediator of lipotoxicity in insulin-producing cells. Diabetes (2010) 1.15
Glucolipotoxicity of the pancreatic beta-cell: myth or reality? Biochem Soc Trans (2008) 1.14
Update on diagnosis, pathogenesis and management of ketosis-prone Type 2 diabetes mellitus. Diabetes Manag (Lond) (2011) 1.00
Effects of palmitate on genome-wide mRNA expression and DNA methylation patterns in human pancreatic islets. BMC Med (2014) 0.98
Dietary macronutrient composition affects β cell responsiveness but not insulin sensitivity. Am J Clin Nutr (2011) 0.91
Lack of lipotoxicity effect on {beta}-cell dysfunction in ketosis-prone type 2 diabetes. Diabetes Care (2009) 0.91
Impaired plasma nonesterified fatty acid tolerance is an early defect in the natural history of type 2 diabetes. J Clin Endocrinol Metab (2008) 0.90
Reevaluation of fatty acid receptor 1 as a drug target for the stimulation of insulin secretion in humans. Diabetes (2013) 0.87
Exogenous insulin enhances glucose-stimulated insulin response in healthy humans independent of changes in free fatty acids. J Clin Endocrinol Metab (2011) 0.87
Fatty acids, insulin resistance, and protein metabolism. J Clin Endocrinol Metab (2009) 0.86
The artificial pancreas: is it important to understand how the β cell controls blood glucose? J Diabetes Sci Technol (2013) 0.86
Nutrigenomics, beta-cell function and type 2 diabetes. Curr Genomics (2007) 0.84
β-Cell lipotoxicity in response to free fatty acid elevation in prepubertal youth: African American versus Caucasian contrast. Diabetes (2013) 0.83
Effects of prolonged fasting and sustained lipolysis on insulin secretion and insulin sensitivity in normal subjects. Am J Physiol Endocrinol Metab (2008) 0.82
Transcriptional regulation of lipid metabolism by fatty acids: a key determinant of pancreatic beta-cell function. Nutr Metab (Lond) (2005) 0.82
Low density lipoprotein delays clearance of triglyceride-rich lipoprotein by human subcutaneous adipose tissue. J Lipid Res (2013) 0.81
A simple matter of life and death-the trials of postnatal Beta-cell mass regulation. Int J Endocrinol (2012) 0.81
Palmitate induces mRNA translation and increases ER protein load in islet β-cells via activation of the mammalian target of rapamycin pathway. Diabetes (2014) 0.80
Small-molecule inhibition of inflammatory β-cell death. Diabetes Obes Metab (2013) 0.80
Type-2 diabetes related intermediate phenotypic traits in north Indian diabetics. Indian J Clin Biochem (2007) 0.78
Obesity and insulin resistance: an abridged molecular correlation. Lipid Insights (2013) 0.78
Effects of acute carbohydrate supplementation during sessions of high-intensity intermittent exercise. Eur J Appl Physiol (2006) 0.77
Obese first-degree relatives of patients with type 2 diabetes with elevated triglyceride levels exhibit increased β-cell function. Metab Syndr Relat Disord (2014) 0.75
Plasma lipid levels predict dysglycemia in a biracial cohort of nondiabetic subjects: Potential mechanisms. Exp Biol Med (Maywood) (2016) 0.75
Serum fatty acid patterns in patients with schizophrenia: a targeted metabonomics study. Transl Psychiatry (2017) 0.75
Quantitative estimation of insulin sensitivity. Am J Physiol (1979) 7.37
Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet (1992) 6.28
Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest (1981) 5.82
Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes (1993) 5.70
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med (1996) 5.20
Assessment of insulin sensitivity in vivo. Endocr Rev (1985) 4.21
Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) Study. Diabetes Care (1998) 3.99
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation (2000) 3.78
MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed (1986) 3.54
Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates. Diabetes (1987) 2.95
Deterioration in renal function associated with fibrate therapy. Clin Nephrol (2001) 2.92
Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest (1987) 2.81
Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study. JAMA (1998) 2.56
Insulin transport across capillaries is rate limiting for insulin action in dogs. J Clin Invest (1989) 2.32
Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study. Arch Intern Med (2001) 2.22
Dietary restriction increases insulin sensitivity and lowers blood glucose in rhesus monkeys. Am J Physiol (1994) 2.13
Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model. Suitability for use in population studies. Diabetes (1993) 2.03
Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs. Proc Natl Acad Sci U S A (1999) 1.91
Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes (1995) 1.91
Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study. J Am Coll Cardiol (1998) 1.88
Dietary restriction and glucose regulation in aging rhesus monkeys: a follow-up report at 8.5 yr. Am J Physiol Endocrinol Metab (2001) 1.86
Familiality of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus. Finland-United States Investigation of NIDDM Genetics (FUSION) Study investigators. Hum Hered (1999) 1.76
A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study. Diabetes (1994) 1.73
Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. J Clin Endocrinol Metab (1990) 1.71
Role of glucose effectiveness in the determination of glucose tolerance. Diabetes Care (1996) 1.68
HDL-cholesterol as a marker of coronary heart disease risk: the Québec cardiovascular study. Atherosclerosis (2000) 1.68
Quantitative estimation of beta cell sensitivity to glucose in the intact organism: a minimal model of insulin kinetics in the dog. Diabetes (1980) 1.67
Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. J Clin Invest (1993) 1.67
Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients. Diabetes Care (1994) 1.67
Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced beta-cell response. Diabetes (2000) 1.63
Possible mechanisms relating diet and risk of colon cancer. Cancer Epidemiol Biomarkers Prev (2000) 1.60
Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J Clin Invest (1996) 1.60
Dietary fat and insulin sensitivity in a triethnic population: the role of obesity. The Insulin Resistance Atherosclerosis Study (IRAS) Am J Clin Nutr (1997) 1.59
Diurnal variation in glucose tolerance. Cyclic suppression of insulin action and insulin secretion in normal-weight, but not obese, subjects. Diabetes (1992) 1.56
Modified protocols improve insulin sensitivity estimation using the minimal model. Am J Physiol (1987) 1.54
Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes. Diabetes (2000) 1.52
The insulin resistance-dyslipidemic syndrome: contribution of visceral obesity and therapeutic implications. Int J Obes Relat Metab Disord (1995) 1.49
Insulin resistance in short children with intrauterine growth retardation. J Clin Endocrinol Metab (1997) 1.48
Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. Am J Obstet Gynecol (1990) 1.48
Minimal models of glucose disappearance: lessons from the labelled IVGTT. Diabet Med (1991) 1.45
Effect of sitagliptin therapy on postprandial lipoprotein levels in patients with type 2 diabetes. Diabetes Obes Metab (2011) 1.45
Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors. J Clin Invest (1996) 1.45
Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased beta-cell function. J Clin Endocrinol Metab (1985) 1.43
The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men. Diabetes Care (1996) 1.43
Ethnic differences in carotid wall thickness. The Insulin Resistance Atherosclerosis Study. Stroke (1996) 1.42
Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study. Diabetes (1997) 1.42
Central role of the adipocyte in insulin resistance. J Basic Clin Physiol Pharmacol (1998) 1.39
A molecular Einstein ring: imaging a starburst disk surrounding a quasi-stellar object. Science (2003) 1.38
Novel glucosensor for hypoglycemic detection localized to the portal vein. Diabetes (1997) 1.36
The modified minimal model: application to measurement of insulin sensitivity in children. J Clin Endocrinol Metab (1990) 1.35
Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. J Clin Invest (1999) 1.35
Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans. Diabetes (1996) 1.31
Effects of endurance exercise training on plasma HDL cholesterol levels depend on levels of triglycerides: evidence from men of the Health, Risk Factors, Exercise Training and Genetics (HERITAGE) Family Study. Arterioscler Thromb Vasc Biol (2001) 1.31
Kinetics and specificity of insulin uptake from plasma into cerebrospinal fluid. Am J Physiol (1990) 1.31
Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans. Diabetes (1997) 1.30
The insulin sensitivity index in nondiabetic man. Correlation between clamp-derived and IVGTT-derived values. Diabetes (1986) 1.30
Mechanisms linking diet and colorectal cancer: the possible role of insulin resistance. Nutr Cancer (2000) 1.30
Peripheral effects of insulin dominate suppression of fasting hepatic glucose production. Am J Physiol (1990) 1.29
Modeling error and apparent isotope discrimination confound estimation of endogenous glucose production during euglycemic glucose clamps. Diabetes (1988) 1.28
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Stat Med (2009) 1.27
Central role of the adipocyte in the metabolic syndrome. J Investig Med (2001) 1.26
Insulin sensitivity from meal tolerance tests in normal subjects: a minimal model index. J Clin Endocrinol Metab (2000) 1.25
Influence of total vs. visceral fat on insulin action and secretion in African American and white children. Obes Res (2001) 1.25
Inhibition of lipolysis causes suppression of endogenous glucose production independent of changes in insulin. Am J Physiol Endocrinol Metab (2000) 1.24
Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats. Diabetes (1999) 1.22
Indirect effect of insulin to suppress endogenous glucose production is dominant, even with hyperglucagonemia. J Clin Invest (1997) 1.22
Transendothelial insulin transport is not saturable in vivo. No evidence for a receptor-mediated process. J Clin Invest (1996) 1.21
Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels in men. Arch Intern Med (2001) 1.20
Intraportal glucose infusion matched to oral glucose absorption. Lack of evidence for "gut factor" involvement in hepatic glucose storage. Diabetes (1982) 1.20
Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity. J Lipid Res (2001) 1.18
Minimal modeling, partition analysis, and the estimation of insulin sensitivity. Fed Proc (1980) 1.18
The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences. Diabetes (2001) 1.17
Primacy of liver glucosensors in the sympathetic response to progressive hypoglycemia. Proc Natl Acad Sci U S A (1994) 1.15
Dynamics of glucose autoregulation in the isolated, blood-perfused canine liver. Am J Physiol (1974) 1.15
Glucose tolerance and insulin action in rats with renovascular hypertension. Hypertension (1991) 1.15
Diminished insulin sensitivity and increased insulin response in nonobese, nondiabetic Mexican Americans. Metabolism (1990) 1.14
Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease. Circulation (2001) 1.14
Portal venous and enteric exocrine drainage versus systemic venous and bladder exocrine drainage of pancreas grafts: clinical outcome of 40 consecutive transplant recipients. Ann Surg (2000) 1.14
Integrated control of hepatic glucose metabolism. Fed Proc (1977) 1.12
Importance of hepatic glucoreceptors in sympathoadrenal response to hypoglycemia. Diabetes (1991) 1.12
The contribution of insulin-dependent and insulin-independent glucose uptake to intravenous glucose tolerance in healthy human subjects. Diabetes (1994) 1.12
HDL metabolism in hypertriglyceridemic states: an overview. Clin Chim Acta (1999) 1.12
Evidence for entry of plasma insulin into cerebrospinal fluid through an intermediate compartment in dogs. Quantitative aspects and implications for transport. J Clin Invest (1991) 1.12
Differential effects of monounsaturated, polyunsaturated and saturated fat ingestion on glucose-stimulated insulin secretion, sensitivity and clearance in overweight and obese, non-diabetic humans. Diabetologia (2006) 1.12
Effects of diet and physical activity on adiposity and body fat distribution: implications for the prevention of cardiovascular disease. Nutr Res Rev (1993) 1.12
Pioglitazone increases insulin sensitivity, reduces blood glucose, insulin, and lipid levels, and lowers blood pressure, in obese, insulin-resistant rhesus monkeys. Diabetes (1994) 1.12
Leptinemia is not a risk factor for ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Diabetes Care (1998) 1.10
Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus. J Clin Invest (1998) 1.09
Importance of glucose per se to intravenous glucose tolerance. Comparison of the minimal-model prediction with direct measurements. Diabetes (1985) 1.09
Increased beta-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance. Diabetes (1989) 1.09
Portal vein afferents are critical for the sympathoadrenal response to hypoglycemia. Diabetes (2000) 1.09